News in brief: Endocrinologists make SGLTi recommendations; Don’t screen for vitamin D deficiency; Bone health concern for AEDs

SGLTi recommendations for GPs SGLT2 inhibitors should be used more widely in people with type 2 diabetes, according to practical recommendations for GPs from endocrinologists published in the Australian Journal of Family Practice, the RACGP’s official journal. The “impressive cardiovascular, renal and metabolic benefits, have modified the paradigm in which we approach diabetes management” according ...

Already a member?

Login to keep reading.

© 2021 the limbic